Group 1 - The Bega Annual General Meeting (AGM) is a formal event being live-streamed for shareholders [1][2] - A quorum has been established, allowing the meeting to commence [2] - Different colored cards were distributed to attendees for voting purposes: yellow for voting shareholders, blue for non-voting shareholders, and red for non-shareholders [3] Group 2 - Shareholders attending the meeting can ask questions, with specific identification required for in-person attendees [4]

Core Viewpoint - A new company, Fuyiao Kejie (Xianning) Dairy Co., Ltd., has been established with a registered capital of 166 million yuan, focusing on various food production and sales activities [1] Company Summary - Fuyiao Kejie (Xianning) Dairy Co., Ltd. is fully owned by Yuanqi Forest (Beijing) Food Technology Group Co., Ltd. [1] - The company's business scope includes dairy product production, food sales, food production, food packaging, health food production, food additives production, and alcoholic beverage operations [1]

Core Insights - The 10th China Special Food Conference highlighted the scientific achievements of Mead Johnson's children's nutrition brand, Xueyouli, particularly its positive impact on children's bone health through its formula containing colostrum alkaline protein and folic acid [1][2] - The research emphasizes the importance of scientific evidence in validating product efficacy and addressing parents' rational needs in children's nutrition [1][2] - Mead Johnson's commitment to scientific research and innovation is underscored by its 120-year history and its dual strategy focusing on both infant and children's adult nutrition [2][3] Group 1 - The study presented at the conference indicates that the combination of colostrum alkaline protein and folic acid in milk powder can activate the GH-IGF-1 axis, supporting linear bone growth and bone mass accumulation in children [2] - The findings suggest that the enhanced nutritional formula not only promotes height growth but also reduces the risk of obesity during puberty and potential long-term metabolic disorders [2] - Mead Johnson's senior vice president emphasized the brand's ability to adapt to consumer needs and its focus on breast milk as the gold standard for research, driving formula innovation through scientific evidence [2][3] Group 2 - The release of this research expands Mead Johnson's scientific evidence into the children's nutrition sector, marking a breakthrough in its dual strategy for infant and children's adult nutrition [3] - Mead Johnson has a decade-long research history in the field of milk fat globule membrane (MFGM) and holds 158 patents, establishing itself as a leader in this area [3] - The two major scientific validations this year further solidify Mead Johnson's industry-leading position and demonstrate its comprehensive and continuous approach to lifecycle nutrition [3]

Core Insights - The company reported a revenue of 120 million yuan for the third quarter, representing a decline of 8.77% compared to the previous year [1] - The net profit for the third quarter was 27.58 million yuan, also down by 8.78% year-on-year [1] - For the first three quarters, the total revenue was 356 million yuan, reflecting a decrease of 7.62% [1] - The net profit for the first three quarters increased to 87.40 million yuan, showing a growth of 2.24% compared to the same period last year [1]

Core Viewpoint - Mengniu Dairy (02319) announced a share buyback plan, intending to repurchase 400,000 shares at a cost of HKD 5.771 million, scheduled for October 27, 2025 [1] Group 1 - The company plans to spend HKD 5.771 million on the buyback [1] - A total of 400,000 shares will be repurchased [1] - The buyback is set to occur on October 27, 2025 [1]

Group 1 - The company, Mengniu Dairy (02319.HK), announced a share buyback plan, intending to repurchase 400,000 shares at a total cost of HKD 5.771 million [1] - The buyback price per share is set between HKD 14.38 and HKD 14.46 [1]

Core Insights - The 10th China Special Food Conference was held in Xi'an from October 23 to 26, 2025, where Aoyou and Jiangnan University signed a six-year strategic cooperation agreement to enhance their collaboration in research and development [1][2] Group 1: Strategic Collaboration - Aoyou aims to leverage technology-driven strategies by establishing two innovation centers with Jiangnan University, marking a new phase in their partnership focused on deep integration of industry, academia, and research [1][2] - The collaboration will enhance Aoyou's development in microecology, functional dairy, and probiotics, providing a strong impetus for the upgrade of China's health food industry [1][2] Group 2: Research and Development Focus - Jiangnan University, recognized as a top institution in food science, will contribute its expertise to Aoyou, which has a global presence in the dairy industry, covering over 60 countries [2][8] - The partnership will focus on "basic research + application development + industrial transformation," creating a new paradigm for innovation collaboration [2][8] Group 3: Innovation Centers - The establishment of the "Jiangnan University-Aoyou Microecology and Functional Dairy Joint Innovation Center" and the "Jiangnan University-Jinqi Biological Probiotics Collaborative Innovation Center" aims to explore new models for raw material development, product innovation, and market promotion [2][8] Group 4: Technology Transfer - Jiangnan University transferred two patented strains, CCFM1025 and CCFM1074, to Jinqi Biological, which will lead to their industrialization and commercial application [10][15] - CCFM1025 has shown significant improvements in sleep quality and cognitive function, while CCFM1074 has been proven to regulate gut microbiota and immune responses [10][15] Group 5: Industry Impact - The collaboration is expected to address the growing demand for functional and precise nutrition products, driven by the increasing health consciousness among consumers [9][10] - Aoyou's partnership with Jiangnan University is seen as a model for integrating research and industry, contributing to the high-quality development of the dairy sector in China [15]

Core Viewpoint - Company maintains an "outperform" rating for Ausnutria (01717), projecting steady revenue growth and significant profit increases from 2025 to 2027 [1][2] Financial Projections - Expected revenue for Ausnutria in 2025, 2026, and 2027 is 7.67 billion, 7.88 billion, and 8.04 billion CNY, reflecting year-on-year growth of 3.6%, 2.8%, and 2.1% respectively [1] - Projected net profit attributable to shareholders for the same years is 310 million, 340 million, and 390 million CNY, with growth rates of 21.0%, 8.0%, and 15.0% [1] - Earnings per share (EPS) are forecasted to be 0.18, 0.19, and 0.22 CNY [1] Market Performance - The overseas market has become the second growth engine for Ausnutria, with revenue growth of 54.2% in the Middle East and 138.7% in North America during the first half of 2025 [1][2] - The company has initiated an internal code system upgrade and inventory adjustments, which, while reducing short-term shipments, are expected to enhance product freshness and channel transparency [2] Strategic Focus - Ausnutria is advancing its internationalization strategy, particularly in the sheep milk powder segment, which is gaining traction in overseas markets [2] - The company has launched brands like Nutrition Care and 爱益森 in the nutrition segment, leveraging scientific strength for category breakthroughs [2] - The dual focus on cow and sheep milk products, along with a comprehensive nutrition strategy, positions Ausnutria for resilient growth in a complex market environment [2]

Core Viewpoint - Haitong International maintains an "outperform" rating for Ausnutria (01717), projecting revenue growth and significant profit increases from 2025 to 2027 [1][2] Financial Projections - Expected revenue for Ausnutria in 2025, 2026, and 2027 is 7.67 billion, 7.88 billion, and 8.04 billion CNY, reflecting year-on-year growth of 3.6%, 2.8%, and 2.1% respectively [1] - Projected net profit attributable to shareholders for the same years is 310 million, 340 million, and 390 million CNY, with growth rates of 21.0%, 8.0%, and 15.0% respectively [1] - Earnings per share (EPS) are forecasted to be 0.18, 0.19, and 0.22 CNY [1] Market Performance - The overseas market has become the second growth engine for Ausnutria, with revenue growth of 54.2% in the Middle East and 138.7% in North America during the first half of 2025 [1][2] Strategic Initiatives - The company initiated an internal code system upgrade and inventory adjustment in the first half of 2025, which, while reducing short-term shipments, improved product freshness and channel transparency [2] - Ausnutria is focusing on deepening its international strategy, leveraging its dual focus on cow and goat milk products to drive growth [2] - The goat milk powder business is making significant strides in overseas markets, with the brand Kabrita being the first goat milk infant formula approved by the US FDA, now available in Walmart and other channels in North America [2] Product Innovation - The company is enhancing its "milk powder + nutrition products" strategy, improving global supply chain management for efficiency and product innovation [2] - New nutrition products like Nutrition Care and Ai Yisen are being introduced, supported by strong research capabilities, contributing to category breakthroughs and injecting new momentum into the company [2] Resilience and Growth Outlook - Ausnutria demonstrates strong corporate resilience, with expectations to maintain steady growth in a complex and changing market environment, driven by rapid overseas market growth, synergies between cow and goat milk products, and a robust nutrition product segment [2]

Core Insights - The 10th China Special Food Conference is being held in Xi'an from October 23 to 26, 2025, marking the 10th anniversary of the China Nutrition and Health Food Association, focusing on the achievements and future development paths of the nutrition and health food industry in China [1] Company Collaboration - Aoyou has signed a strategic cooperation agreement with Jiangnan University to establish two innovation centers, enhancing the integration of production, learning, research, and application [1][3] - The collaboration aims to inject stronger momentum into Aoyou's micro-ecology, functional dairy, and probiotic business development, while providing continuous power for the upgrade of China's health food industry [1][3] Research and Development - The strategic cooperation agreement spans six years, focusing on "basic research + application development + industrial transformation," creating a new paradigm for collaborative innovation [3][5] - Aoyou and Jiangnan University have established the "Jiangnan University-Aoyou Dairy Micro-ecology and Functional Dairy Joint Innovation Center" to deliver safer and more precise nutritional solutions to global consumers [3][5] Achievements and Future Plans - Since the first strategic agreement in 2017, the partnership has expanded research areas and upgraded cooperation models, leading to significant breakthroughs in functional dairy and probiotics [5] - The collaboration has resulted in the establishment of a national-level probiotic demonstration production line, the only one in the industry, which commenced operations in 2023 [5] Product Innovation - Jiangnan University has transferred two strains and their patents to Aoyou, initiating the industrialization and commercial application of these strains [10] - The strains CCFM1025 and CCFM1074 have shown significant potential in improving sleep quality, emotional regulation, and immune balance, with multiple patents and publications supporting their efficacy [10][11] Industry Context - The global nutrition food industry is experiencing unprecedented growth opportunities, driven by the increasing demand for precise nutrition and functional products [10] - Aoyou aims to leverage its global industrial chain advantages to overcome key technological challenges and accelerate product innovation and market expansion [7][10]